Regeneron Pharmaceuticals, Inc. financial data

Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
Location
777 Old Saw Mill River Road, Tarrytown, New York
State of incorporation
New York
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 539 % +2.8%
Quick Ratio 75.6 % -2.82%
Debt-to-equity 27.9 % -4.95%
Return On Equity 15.2 % -20.1%
Return On Assets 11.9 % -19.2%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 76.7B USD +23.7%
Weighted Average Number of Shares Outstanding, Basic 108M shares +0.65%
Weighted Average Number of Shares Outstanding, Diluted 115M shares +0.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 13.1B USD +5.9%
Research and Development Expense 4.59B USD +19.1%
Costs and Expenses 9.25B USD +16.4%
Operating Income (Loss) 3.85B USD -13%
Nonoperating Income (Expense) 190M USD -16.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.04B USD -13.2%
Income Tax Expense (Benefit) 184M USD -61.1%
Net Income (Loss) Attributable to Parent 3.86B USD -7.77%
Earnings Per Share, Basic 36.1 USD/shares -7.48%
Earnings Per Share, Diluted 33.9 USD/shares -7.91%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.6B USD -33.6%
Marketable Securities, Current 7.92B USD +57%
Accounts Receivable, after Allowance for Credit Loss, Current 5.22B USD +2.02%
Inventory, Net 2.71B USD +12%
Assets, Current 18.9B USD +11.6%
Deferred Income Tax Assets, Net 2.76B USD +43.6%
Property, Plant and Equipment, Net 3.7B USD +9.09%
Operating Lease, Right-of-Use Asset 78M USD +9.55%
Intangible Assets, Net (Excluding Goodwill) 1.06B USD +14%
Other Assets, Noncurrent 470M USD +34.5%
Assets 34.4B USD +14.3%
Accounts Payable, Current 671M USD +12%
Employee-related Liabilities, Current 618M USD +24.3%
Contract with Customer, Liability, Current 517M USD +21.2%
Liabilities, Current 3.58B USD +15.5%
Contract with Customer, Liability, Noncurrent 186M USD +117%
Operating Lease, Liability, Noncurrent 68.7M USD +23.1%
Other Liabilities, Noncurrent 909M USD +34.1%
Liabilities 7.38B USD +12.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -77.2M USD +57.5%
Retained Earnings (Accumulated Deficit) 28B USD +16%
Stockholders' Equity Attributable to Parent 27B USD +14.9%
Liabilities and Equity 34.4B USD +14.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.51B USD +10.6%
Net Cash Provided by (Used in) Financing Activities 47.1M USD
Net Cash Provided by (Used in) Investing Activities -1.69B USD -616%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -128M USD -116%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.61B USD -33.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 73.1M USD +36.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 2.63B USD +47.4%
Operating Lease, Liability 87.7M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.96B USD -5.01%
Lessee, Operating Lease, Liability, to be Paid 103M USD
Operating Lease, Liability, Current 19M USD +53.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 24.1M USD
Deferred Income Tax Expense (Benefit) -838M USD -12.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15.6M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.6M USD
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -835M USD -4.61%
Current Income Tax Expense (Benefit) 1.08B USD -14.5%
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 696M USD +28.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.4M USD
Operating Lease, Payments 22.5M USD +192%
Additional Paid in Capital 11.9B USD +12.7%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 7.7M USD +4.05%
Current Federal Tax Expense (Benefit) 668M USD -31%
Amortization of Intangible Assets 92.2M USD +145%
Depreciation, Depletion and Amortization 114M USD +14.7%
Deferred State and Local Income Tax Expense (Benefit) -6.5M USD -141%
Interest Expense 71.1M USD +11.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%